X0306 4/A 2020-05-28 2020-05-29 0 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001452429 Truitt Joseph C/O BIOSPECIFICS TECHNOLOGIES CORP. 2 RIGHTER PKWY, DELAWARE CORP. CENTER II WILMINGTON DE 19803 1 1 0 0 Chief Executive Officer Stock Option (Right to Buy) 63.72 2020-05-28 4 A 0 100000 0.00 A 2030-05-28 Common Stock 100000 100000 D The stock options were granted under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan (the "Plan"). As previously reported on a Form 4 filed on May 29, 2020 by the reporting person, the reporting person reported acquiring stock options to purchase 130,000 shares of common stock. However, BioSpecifics Technologies Corp. (the "Company") subsequently determined that stock options to purchase 30,000 shares of common stock under the Plan were not validly granted pursuant to the Plan because they exceeded the Plan limit on the number of stock options that may be granted to any newly-hired employee participant in any one calendar year. Accordingly, the attempted grant of these excess stock options was ineffective, and they were never granted to the reporting person. The reporting person is filing this amendment to report the correct amount of stock options acquired. The stock options vest in four equal installments over the four-year period following the date of grant. /s/ Joseph E. Truitt by Carl A. Valenstein, attorney- in-fact 2020-10-19